annual CAPEX:
$2.28B-$1.04B(-31.37%)Summary
- As of today (August 16, 2025), TAK annual capital expenditures is $2.28 billion, with the most recent change of -$1.04 billion (-31.37%) on March 1, 2025.
- During the last 3 years, TAK annual CAPEX has risen by +$626.13 million (+37.82%).
- TAK annual CAPEX is now -51.21% below its all-time high of $4.68 billion, reached on March 31, 2023.
Performance
TAK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$519.07M-$92.30M(-15.10%)Summary
- As of today (August 16, 2025), TAK quarterly capital expenditures is $519.07 million, with the most recent change of -$92.30 million (-15.10%) on June 1, 2025.
- Over the past year, TAK quarterly CAPEX has dropped by -$465.54 million (-47.28%).
- TAK quarterly CAPEX is now -84.50% below its all-time high of $3.35 billion, reached on March 31, 2023.
Performance
TAK quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$2.03B-$465.54M(-18.68%)Summary
- As of today (August 16, 2025), TAK TTM capital expenditures is $2.03 billion, with the most recent change of -$465.54 million (-18.68%) on June 1, 2025.
- Over the past year, TAK TTM CAPEX has dropped by -$327.13 million (-13.90%).
- TAK TTM CAPEX is now -67.14% below its all-time high of $6.17 billion, reached on December 31, 2023.
Performance
TAK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TAK CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.4% | -47.3% | -13.9% |
| 3 y3 years | +37.8% | -31.6% | -0.2% |
| 5 y5 years | +13.9% | +38.0% | +1.9% |
TAK CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -51.2% | +37.8% | -84.5% | +110.3% | -67.1% | +11.3% |
| 5 y | 5-year | -51.2% | +37.8% | -84.5% | +110.3% | -67.1% | +22.3% |
| alltime | all time | -51.2% | +902.1% | -84.5% | +485.8% | -67.1% | +2187.4% |
TAK CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $519.07M(-15.1%) | $2.03B(-18.7%) |
| Mar 2025 | $2.28B(-31.4%) | $611.37M(+84.8%) | $2.49B(+4.2%) |
| Dec 2024 | - | $330.81M(-41.5%) | $2.39B(-5.5%) |
| Sep 2024 | - | $565.53M(-42.6%) | $2.53B(+7.6%) |
| Jun 2024 | - | $984.61M(+92.6%) | $2.35B(-29.3%) |
| Mar 2024 | $3.32B(-28.9%) | $511.25M(+8.5%) | $3.33B(-46.0%) |
| Dec 2023 | - | $471.32M(+21.9%) | $6.17B(+2.2%) |
| Sep 2023 | - | $386.74M(-80.3%) | $6.04B(+2.4%) |
| Jun 2023 | - | $1.96B(-41.4%) | $5.90B(+25.6%) |
| Mar 2023 | $4.68B(+182.5%) | $3.35B(+888.1%) | $4.69B(+157.6%) |
| Dec 2022 | - | $338.83M(+37.3%) | $1.82B(-3.3%) |
| Sep 2022 | - | $246.87M(-67.5%) | $1.88B(-7.2%) |
| Jun 2022 | - | $759.22M(+59.3%) | $2.03B(+22.5%) |
| Mar 2022 | $1.66B(-25.7%) | $476.49M(+18.7%) | $1.66B(-25.3%) |
| Dec 2021 | - | $401.29M(+2.1%) | $2.22B(-1.3%) |
| Sep 2021 | - | $392.99M(+1.7%) | $2.25B(+0.3%) |
| Jun 2021 | - | $386.38M(-62.8%) | $2.24B(+0.5%) |
| Mar 2021 | $2.23B(+11.3%) | $1.04B(+141.5%) | $2.23B(+25.9%) |
| Dec 2020 | - | $429.95M(+11.4%) | $1.77B(-13.7%) |
| Sep 2020 | - | $386.06M(+2.6%) | $2.05B(+3.2%) |
| Jun 2020 | - | $376.15M(-35.1%) | $1.99B(-0.7%) |
| Mar 2020 | $2.00B(+65.6%) | $579.25M(-18.6%) | $2.00B(+8.9%) |
| Dec 2019 | - | $711.22M(+121.2%) | $1.84B(+31.5%) |
| Sep 2019 | - | $321.57M(-17.8%) | $1.40B(+9.5%) |
| Jun 2019 | - | $391.06M(-5.8%) | $1.28B(+5.6%) |
| Mar 2019 | $1.21B(+4.5%) | $415.29M(+53.6%) | $1.21B(+16.4%) |
| Dec 2018 | - | $270.31M(+34.6%) | $1.04B(+11.6%) |
| Sep 2018 | - | $200.81M(-37.9%) | $931.51M(-24.4%) |
| Jun 2018 | - | $323.31M(+32.0%) | $1.23B(+6.4%) |
| Mar 2018 | $1.16B(+11.9%) | $244.96M(+50.8%) | $1.16B(-9.3%) |
| Dec 2017 | - | $162.44M(-67.6%) | $1.28B(-10.3%) |
| Sep 2017 | - | $501.58M(+101.7%) | $1.42B(+23.6%) |
| Jun 2017 | - | $248.65M(-31.6%) | $1.15B(+11.1%) |
| Mar 2017 | $1.03B(+46.4%) | $363.43M(+17.5%) | $1.04B(+17.8%) |
| Dec 2016 | - | $309.21M(+34.6%) | $879.64M(+17.5%) |
| Sep 2016 | - | $229.78M(+72.1%) | $748.65M(+5.1%) |
| Jun 2016 | - | $133.51M(-35.5%) | $712.03M(+0.7%) |
| Mar 2016 | $706.65M | $207.15M(+16.2%) | $707.15M(-4.9%) |
| Dec 2015 | - | $178.23M(-7.7%) | $743.76M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $193.16M(+50.2%) | $746.92M(+2.2%) |
| Jun 2015 | - | $128.62M(-47.2%) | $731.16M(-26.5%) |
| Mar 2015 | $989.64M(+26.3%) | $243.76M(+34.4%) | $994.18M(+1.5%) |
| Dec 2014 | - | $181.38M(+2.2%) | $979.10M(+2.9%) |
| Sep 2014 | - | $177.40M(-54.7%) | $951.59M(-7.2%) |
| Jun 2014 | - | $391.63M(+71.3%) | $1.03B(+30.8%) |
| Mar 2014 | $783.85M(-42.1%) | $228.69M(+48.6%) | $783.95M(+41.2%) |
| Dec 2013 | - | $153.87M(-38.8%) | $555.26M(+38.3%) |
| Sep 2013 | - | $251.58M(+67.9%) | $401.39M(+167.9%) |
| Jun 2013 | - | $149.81M(+61.4%) | $149.81M(-89.6%) |
| Mar 2013 | $1.35B(+72.7%) | - | - |
| Mar 2012 | $783.98M(-45.9%) | - | - |
| Mar 2011 | $1.45B(+54.8%) | $92.82M(-74.2%) | $1.44B(-14.4%) |
| Dec 2010 | - | $359.14M(-22.9%) | $1.68B(+2.7%) |
| Sep 2010 | - | $465.52M(-11.3%) | $1.64B(+19.5%) |
| Jun 2010 | - | $524.57M(+56.5%) | $1.37B(+46.5%) |
| Mar 2010 | $936.40M(+138.7%) | $335.27M(+6.4%) | $937.22M(+55.7%) |
| Dec 2009 | - | $314.99M(+58.8%) | $601.95M(+109.8%) |
| Sep 2009 | - | $198.35M(+123.9%) | $286.95M(+223.9%) |
| Jun 2009 | - | $88.61M | $88.61M |
| Mar 2009 | $392.37M(+37.5%) | - | - |
| Mar 2008 | $285.40M(+14.5%) | - | - |
| Mar 2007 | $249.34M(-12.1%) | - | - |
| Mar 2006 | $283.53M(-43.2%) | - | - |
| Mar 2005 | $499.30M(+4.2%) | - | - |
| Mar 2004 | $479.29M(+74.5%) | - | - |
| Mar 2003 | $274.63M(-8.5%) | - | - |
| Mar 2002 | $300.28M(+23.3%) | - | - |
| Mar 2001 | $243.63M(-23.4%) | - | - |
| Mar 2000 | $318.09M(+39.7%) | - | - |
| Mar 1999 | $227.69M(-17.7%) | - | - |
| Mar 1998 | $276.53M(-1.7%) | - | - |
| Mar 1997 | $281.26M(+6.1%) | - | - |
| Mar 1996 | $265.05M(-42.5%) | - | - |
| Mar 1995 | $460.97M(+28.1%) | - | - |
| Mar 1994 | $359.84M(+7.1%) | - | - |
| Mar 1993 | $336.03M(+14.9%) | - | - |
| Mar 1992 | $292.57M(-11.7%) | - | - |
| Mar 1991 | $331.18M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual capital expenditures?
- What is the all time high annual CAPEX for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual CAPEX year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly CAPEX year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM capital expenditures?
- What is the all time high TTM CAPEX for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM CAPEX year-on-year change?
What is Takeda Pharmaceutical Company Limited annual capital expenditures?
The current annual CAPEX of TAK is $2.28B
What is the all time high annual CAPEX for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual capital expenditures is $4.68B
What is Takeda Pharmaceutical Company Limited annual CAPEX year-on-year change?
Over the past year, TAK annual capital expenditures has changed by -$1.04B (-31.37%)
What is Takeda Pharmaceutical Company Limited quarterly capital expenditures?
The current quarterly CAPEX of TAK is $519.07M
What is the all time high quarterly CAPEX for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly capital expenditures is $3.35B
What is Takeda Pharmaceutical Company Limited quarterly CAPEX year-on-year change?
Over the past year, TAK quarterly capital expenditures has changed by -$465.54M (-47.28%)
What is Takeda Pharmaceutical Company Limited TTM capital expenditures?
The current TTM CAPEX of TAK is $2.03B
What is the all time high TTM CAPEX for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM capital expenditures is $6.17B
What is Takeda Pharmaceutical Company Limited TTM CAPEX year-on-year change?
Over the past year, TAK TTM capital expenditures has changed by -$327.13M (-13.90%)